What Is the EAT-10?
The Eating Assessment Tool-10 (EAT-10) is a 10-item patient self-administered dysphagia screening questionnaire that quantifies the degree to which swallowing problems interfere with the speaker’s daily function. It was published by Belafsky, Mouadeb, Rees, Pryor, Postma, Allen, & Leonard (2008) in the Annals of Otology, Rhinology & Laryngology as the brief, validated self-report counterpart to longer quality-of-life instruments like the SWAL-QOL (Swallowing Quality of Life, 44 items).
Why a patient-reported outcome for dysphagia. Swallowing problems produce measurable physiologic findings on instrumental studies — but the same oropharyngeal penetration or residue can produce very different impacts on different patients. An older adult with mild pharyngeal residue on VFSS may report severe swallowing handicap; a younger adult with the same finding may report minimal impact. The EAT-10 quantifies what the patient actually experiences, not what the fluoroscopic image suggests, and it is the most widely used patient-reported outcome measure for dysphagia worldwide.
Ten items, one sum. The EAT-10 is a unidimensional scale — there are no sub-scales. All 10 items are rated on the same 5-point Likert scale (0 = No problem, 1 = Slight, 2 = Moderate, 3 = Severe, 4 = Extreme) and summed to a total of 0 - 40. The items cover weight loss, restricted eating out, liquid swallowing effort, solid swallowing effort, pill swallowing effort, painful swallow, lost pleasure of eating, food sticking in the throat, cough with eating, and stress with swallowing. The items were selected during the Belafsky et al. (2008) validation by retaining the items with the highest item-total correlations and the clearest discrimination between healthy controls and dysphagic patients.
Abnormality cutoff
≥ 3. The Belafsky et al. (2008) validation reported a mean EAT-10 of 0.40 (SD 1.01) in healthy controls and statistically elevated scores across oropharyngeal dysphagia, voice, reflux, and head-and-neck cancer populations. The abnormality cutoff of 3 is the score at or above which the patient reports a clinically meaningful swallowing problem and warrants a swallowing work-up. Any total of 3 or higher is abnormal regardless of severity band — the mild / moderate / severe sub-bands surfaced by this calculator are descriptive only and support documentation and trend tracking.
How to Administer the EAT-10
The standard dysphagia clinic procedure for the EAT-10:
1. Screen at intake. Administer the EAT-10 at the initial dysphagia evaluation alongside the patient interview and before the clinical swallow examination. Hand the form to the patient (paper or tablet) and ask them to rate each item based on their current swallowing function. Allow 2 - 4 minutes for completion; do not coach the patient on the "correct" answers.
2. Self-report only. The EAT-10 is a patient-reported outcome measure — the score must come from the patient’s perception, not from the clinician’s observation or from a family member’s description. If the patient cannot complete the form independently because of cognitive, linguistic, or motor impairment, document the reason and use a caregiver-proxy version or a bedside clinical screen (Yale Swallow Protocol, TOR-BSST, GUSS) instead.
3. Score and document. Enter the 10 ratings into this calculator. Document the total, the abnormality flag (
≥ 3), the severity band, and the date in the chart note. An abnormality flag of Yes triggers a clinical swallow examination and, when indicated by the bedside exam, an instrumental study (flexible endoscopic evaluation of swallowing, or videofluoroscopic swallow study).
4. Re-administer at progress milestones. Re-administer the EAT-10 at every major progress milestone in dysphagia management — typically every 4 - 8 weeks of therapy or at any change in diet texture, posture strategy, or medical status — and at discharge. Compare the new total to baseline and document the trajectory.
5. Pair with the rest of the swallowing battery. The EAT-10 quantifies impact; it does not quantify mechanism. Pair with a clinical swallow examination, an instrumental study (FEES or VFSS) when indicated, a nutritional and hydration assessment, and a respiratory status review. The EAT-10 does not exclude silent aspiration — patients with known dysphagia risk factors should be screened with an instrumental study even when the EAT-10 is in the normal range.
The ≥ 3 Abnormality Cutoff and Severity Bands
The single validated decision point in the EAT-10 is the Belafsky et al. (2008) abnormality cutoff of ≥ 3. A total at or above 3 is abnormal and warrants a swallowing work-up regardless of severity band. The mild / moderate / severe sub-bands surfaced by this calculator are descriptive only and are consistent with Belafsky et al. (2008) and subsequent clinical use (Cheney et al. 2015 Dysphagia 30(2):216-220; Rofes et al. 2014 Neurogastroenterology & Motility 26(9):1256-1265).
Normal / asymptomatic (0 - 2). Below the Belafsky et al. (2008) abnormality cutoff of 3. Within the asymptomatic range for self-perceived swallowing function. Document the score and re-screen if new symptoms emerge or at scheduled follow-up for patients with known dysphagia risk factors (stroke, head-and-neck cancer, neurodegenerative disease, chronic obstructive pulmonary disease, tracheostomy, dementia). A low EAT-10 does not exclude silent aspiration — patients at high risk should be screened with an instrumental study regardless of the EAT-10 total.
Mild dysphagia symptoms (3 - 14). Meets the Belafsky et al. (2008) abnormality cutoff. Occasional self-perceived swallowing problems. Refer for a clinical swallow examination and consider an instrumental study (FEES or VFSS) if the symptoms affect nutrition, hydration, or airway protection. Re-screen the EAT-10 at scheduled progress milestones and after any change in swallowing status.
Moderate dysphagia symptoms (15 - 27). Regular self-perceived swallowing problems on most meals with measurable functional impact. Refer for a clinical swallow examination and an instrumental study (FEES or VFSS) to characterise oral, pharyngeal, and airway-protection physiology. Document the textures affected, the weight trajectory, and the hydration status. Coordinate with the medical team on nutrition support if intake is compromised.
Severe dysphagia symptoms (28 - 40). Pervasive self-perceived swallowing problems across most textures and situations. Urgent referral for instrumental swallowing evaluation (FEES or VFSS) and medical work-up. Screen for aspiration risk, weight loss, dehydration, and recurrent lower respiratory infection. Coordinate with otolaryngology, gastroenterology, and nutrition. Chronic dysphagia at this severity is associated with elevated morbidity and hospital readmission.
Using the EAT-10 in Practice
The EAT-10 is the gold-standard patient-reported screener for dysphagia, but it is most useful when paired with the rest of the swallowing battery and tracked across treatment.
At intake. Administer the EAT-10 at the initial dysphagia evaluation, complete the clinical swallow examination, and order an instrumental study (flexible endoscopic evaluation of swallowing, or videofluoroscopic swallow study) when indicated by the bedside exam. The EAT-10 quantifies how much the swallowing problem matters to the patient; the instrumental study quantifies why the swallowing problem exists. Treatment planning needs both.
At treatment progress. Re-administer the EAT-10 at every 4 - 8 weeks of dysphagia therapy and at every change in diet texture, posture strategy, or medical status. Document the EAT-10 trajectory in the SOAP note alongside the bedside swallow findings and the instrumental imaging so the treatment narrative captures both the patient-reported outcome and the clinician-rated and instrumental outcomes.
At discharge. Re-administer the EAT-10 at the discharge visit and report the change from baseline. A return to the normal band (0 - 2) sustained across two consecutive administrations is a reasonable discharge criterion provided the instrumental study also shows improvement and the patient’s weight, hydration, and respiratory status are stable. Do not discharge solely on the basis of the EAT-10.
In head-and-neck cancer. The EAT-10 is a standard intake for head-and-neck cancer patients before, during, and after chemoradiation. Screen at the pre-treatment baseline, at the end of radiation, at 3 months post, at 6 months post, and at every annual follow-up. The EAT-10 trajectory anchors the decision to escalate to a videofluoroscopic swallow study, to a dilation procedure, or to a change in swallowing therapy.
In stroke rehabilitation. The EAT-10 complements bedside swallow screens like the Yale Swallow Protocol and clinical observation of the water swallow test. For stroke patients with aphasia or cognitive-communication impairment who cannot self-complete the EAT-10, document the limitation and use a caregiver-proxy version or a bedside clinical screen instead.
